about
Advanced drug delivery and targeting technologies for the ocular diseasesNanomedicine approaches for corneal diseasesCorneal gene therapy: basic science and translational perspectiveA partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticlesNanomedicine in the application of uveal melanomaContrasting effects of nanoparticle-protein attraction on amyloid aggregationGene therapy in the cornea: 2005--present.Nonviral gene delivery: principle, limitations, and recent progress.Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retinaGene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa.Optically induced cell fusion using bispecific nanoparticles.Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.Enhanced delivery of biodegradable mPEG-PLGA-PLL nanoparticles loading Cy3-labelled PDGF-BB siRNA by UTMD to rat retina.Chitosan nanoparticles for drug delivery to the eye.Progress toward effective treatments for human photoreceptor degenerations.Microvascular modifications in diabetic retinopathy.Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics.Regenerative nanomedicine and the treatment of degenerative retinal diseases.Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.Contact lenses as drug reservoirs & delivery systems: the successes & challenges.Nanocarriers of nanotechnology in retinal diseases.Application of lipid nanoparticles to ocular drug delivery.Transfection efficiency of chitosan and thiolated chitosan in retinal pigment epithelium cells: A comparative study.Nanoparticles for drug delivery to the anterior segment of the eye.Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles.Nuclear targeted delivery of macromolecules to retina and cornea.Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy.A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model.Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy.[Use of nanoparticles in ophthalomology].
P2860
Q26747220-945E7325-60C1-4FC4-BB02-EBE6AF431419Q27022253-97F26C07-2A9F-4FE1-BB47-6576E118DF36Q27027504-621BB17F-B823-4FAF-97D9-F5F8877A11ADQ27349737-92E027E6-6A09-4B0F-84B4-5A9460253802Q28079572-E8219E70-8B86-47D6-AB59-E2E58A0C7567Q28389698-A250AAF2-090E-48A8-A1D7-25428E69FB1AQ30459643-BCB7F78E-EFB3-4A81-9669-3988767068EEQ30479098-417737B6-FDCB-4182-8530-931535D7078CQ33510137-E77FD9F3-F9C3-4129-8204-56757A5482C8Q33752902-C1393A95-952F-4A22-A617-F292F3D348F7Q34780023-15AAB943-E8CC-425F-BA07-E6CAB1A39029Q34982118-509D1679-34BD-4F46-BEC3-9D61D19E52C2Q35027496-7A51927A-4859-45B2-BBC7-ADEA1F8AA542Q36147481-F8AE78F5-FB6D-445B-BA72-B446C8EE013AQ36388879-3DCAE492-D90C-4993-819E-3BDAE379E6F1Q37416144-6933304A-4082-48CC-A10B-64424ED65C82Q37469575-71659B1C-137C-412D-848A-D77ECBB0B8F9Q37879581-0FFC4C2D-DBF7-49C2-B97D-F4FD2D0E8D78Q37942156-DEC2B1A5-8F58-4DC2-8F64-3964018D5B2DQ37968572-F0A8FD9E-6464-44DD-95EC-D5DD06F58639Q38063945-7BB8CB5F-3CF6-4AA4-8565-3406C3B80142Q38270688-7C97E5F0-748E-45E9-BC90-D3FA48D35F67Q38282885-800FFB23-A154-4397-A872-B82906B127F2Q38862505-544096E6-F712-41F9-BC83-C3AB60EAF934Q39129095-F71EC44F-B1D4-4EB1-8DE9-677EABF51178Q39230212-B3EECBCD-4351-4FA1-B18C-D7313CA92366Q40010634-E053C283-9F0C-4282-B76F-CFF774B64494Q44500582-3513FC60-A960-4C20-8812-C611D864FE8FQ45869238-C5C1E547-ED49-46F3-AD84-D95F629655E8Q45880556-927C8681-E200-477D-A5B1-D42121FA21AEQ48735724-3F28FB4B-8A35-4C45-AD35-3BF7ADA48DE0Q54358989-0ED923A6-A677-46DC-A6D9-19F75348447B
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nanoparticle applications in ocular gene therapy
@en
type
label
Nanoparticle applications in ocular gene therapy
@en
prefLabel
Nanoparticle applications in ocular gene therapy
@en
P2860
P1433
P1476
Nanoparticle applications in ocular gene therapy.
@en
P2093
P2860
P304
P356
10.1016/J.VISRES.2007.07.012
P577
2007-09-06T00:00:00Z